Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.77
+0.17 (2.95%)
Nov 21, 2024, 1:34 PM EST - Market open
Terns Pharmaceuticals Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 |
| Cash & Equivalents | 270.14 | 79.93 | 143.24 | 47.7 | 74.85 | 12.33 | Upgrade
|
| Short-Term Investments | 102.64 | 183.51 | 139.88 | 118.28 | - | 7.32 | Upgrade
|
| Cash & Short-Term Investments | 372.78 | 263.44 | 283.11 | 165.98 | 74.85 | 19.65 | Upgrade
|
| Cash Growth | 39.83% | -6.95% | 70.57% | 121.74% | 280.94% | -77.38% | Upgrade
|
| Receivables | - | - | - | - | 12.72 | - | Upgrade
|
| Prepaid Expenses | 3.73 | 3.99 | 2.07 | 0.95 | 1.16 | - | Upgrade
|
| Other Current Assets | - | - | - | - | 2.14 | 2.57 | Upgrade
|
| Total Current Assets | 376.51 | 267.43 | 285.19 | 166.93 | 90.87 | 22.22 | Upgrade
|
| Property, Plant & Equipment | 1.67 | 1.03 | 1.8 | 1.05 | 1.18 | 0.96 | Upgrade
|
| Other Long-Term Assets | 0.06 | 0.06 | 0.04 | 0.09 | 0.25 | 0.72 | Upgrade
|
| Total Assets | 378.23 | 268.52 | 287.03 | 168.07 | 92.29 | 23.9 | Upgrade
|
| Accounts Payable | 1.79 | 2.52 | 1.65 | 2.13 | 0.94 | 1.64 | Upgrade
|
| Accrued Expenses | 8.88 | 8.55 | 5.98 | 4.34 | 8.01 | 3.2 | Upgrade
|
| Short-Term Debt | - | - | - | - | 12.88 | - | Upgrade
|
| Current Portion of Leases | 0.27 | 0.6 | 0.66 | - | - | - | Upgrade
|
| Other Current Liabilities | 0.48 | 0.28 | 0.19 | 0.36 | 1 | 0.12 | Upgrade
|
| Total Current Liabilities | 11.41 | 11.94 | 8.47 | 6.82 | 22.82 | 4.95 | Upgrade
|
| Long-Term Leases | 1.03 | - | 0.54 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.32 | 1.21 | 1.07 | 0.95 | 0.88 | 0.63 | Upgrade
|
| Total Liabilities | 13.76 | 13.15 | 10.08 | 7.77 | 23.7 | 5.58 | Upgrade
|
| Common Stock | 0.01 | 0.01 | 0.01 | 0 | - | - | Upgrade
|
| Additional Paid-In Capital | 763.98 | 588.01 | 520.18 | 342.71 | 14.6 | 1.21 | Upgrade
|
| Retained Earnings | -399.68 | -332.63 | -242.42 | -182.07 | -131.92 | -91.86 | Upgrade
|
| Comprehensive Income & Other | 0.16 | -0.02 | -0.82 | -0.34 | -0.12 | -0.11 | Upgrade
|
| Total Common Equity | 364.47 | 255.37 | 276.94 | 160.3 | -117.44 | -90.76 | Upgrade
|
| Minority Interest | - | - | - | - | - | 14.12 | Upgrade
|
| Shareholders' Equity | 364.47 | 255.37 | 276.94 | 160.3 | 68.59 | 18.32 | Upgrade
|
| Total Liabilities & Equity | 378.23 | 268.52 | 287.03 | 168.07 | 92.29 | 23.9 | Upgrade
|
| Total Debt | 1.31 | 0.6 | 1.21 | - | 12.88 | - | Upgrade
|
| Net Cash (Debt) | 371.47 | 262.84 | 281.91 | 165.98 | 61.97 | 19.65 | Upgrade
|
| Net Cash Growth | 39.74% | -6.77% | 69.84% | 167.83% | 215.39% | -77.38% | Upgrade
|
| Net Cash Per Share | 4.97 | 3.69 | 7.82 | 7.31 | 217.33 | 107.22 | Upgrade
|
| Filing Date Shares Outstanding | 84.94 | 64.65 | 56.67 | 25.27 | 25.13 | 0.18 | Upgrade
|
| Total Common Shares Outstanding | 84.92 | 64.58 | 53.72 | 25.27 | 0.34 | 0.18 | Upgrade
|
| Working Capital | 365.09 | 255.49 | 276.72 | 160.11 | 68.05 | 17.27 | Upgrade
|
| Book Value Per Share | 4.29 | 3.95 | 5.16 | 6.34 | -347.97 | -495.25 | Upgrade
|
| Tangible Book Value | 364.47 | 255.37 | 276.94 | 160.3 | -117.44 | -90.76 | Upgrade
|
| Tangible Book Value Per Share | 4.29 | 3.95 | 5.16 | 6.34 | -347.97 | -495.25 | Upgrade
|
| Machinery | - | 1.38 | 1.4 | 1.3 | 0.97 | 0.46 | Upgrade
|
| Leasehold Improvements | - | 0.73 | 0.76 | 0.93 | 0.9 | 0.77 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.